2Dietz JD, Du S, Bolten CW, et al. A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity[ J]. Hypertension ,2008,51 (3) :742-748.
5Haws CW, Gourley JK, Heistad DD. Effects of nimodipine on cerebral blood flow[J]. J Pharmacol Exp Ther,1983,225( 1 ) :24-28.
6Haws CW, Heistad DD. Effects of nimodipine on cerebral vasoconstrictor responses [ J]. Am J Physiol, 1984,247 ( 2 Pt 2 ) : H170- H176.
7Uematsu D, Greenberg JH, Hickey WF, et al. Nimodipine attenuates both increase in cytosolic free calcium and histolagic damage following focal cerebral ischemia and reperfusion in cats[ J]. Stroke, 1989,20( 11 ) :1531-1537.
5BanksP,Franks NP,Dicknson R.Compedtive inhibition at the glycine site of the Nmethyl-D -aspartate receptor mediates xenon neuroproteetion against hypoxia -ischemia [J],Anesthesiology,2010,112(3) :614-622.
8LimatolaV,Ward P,Catrand D,et al.Xenon preconditioning confers neuroprotecfionregardless of gender in a mouse model of transient middle cerebral artery occlusion [J].Neuroscience,2010,165(3) :874-881.
